HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tzy-Haw Wu Selected Research

nicametate

1/2021Impacts of treatments on recurrence and 28-year survival of ischemic stroke patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tzy-Haw Wu Research Topics

Disease

2Ischemic Stroke
01/2021 - 01/2013
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2021
1Stroke (Strokes)
01/2021
1Epilepsy (Aura)
11/2019

Drug/Important Bio-Agent (IBA)

1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021
1nicametateIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2013

Therapy/Procedure

1Therapeutics
01/2021
1Emergency Treatment
11/2019